21 MEDICAL INNOVATIONS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
21 MEDICAL INNOVATIONS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
Copy
Website
-
Not calculatedReliability
Prescore cannot be calculated because the company delayed submission of financial statements.
Incorporation date
15/11/2019Share capital
5,000.00 PLNPrimary activity
Wholesale of pharmaceutical goods (46.46.Z - PKD 2007)Representatives
1Representatives rights
JEŻELI ZARZĄD SKŁADA SIĘ Z JEDNEGO CZŁONKA BĘDĄCEGO PREZESEM SPÓŁKI, SPÓŁKA JEST REPREZENTOWANA JEDNOOSOBOWO. JEŻELI ZARZĄD JEST WIELOOSOBOWY, SPÓŁKĘ MOŻE REPREZENTOWAĆ KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE.Representatives
Business linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
Filip Skrzypiec | Chairman of the management board |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
-8,307Net Profit (zł)
-8,307Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2021 |
|---|
| 394,469 |
| -30,325 |
| -30,325 |
| 1.08 |
| 7.27 |
| -7.69 |
| 424,322 |
| 67,637 |
| 0 |
| - |
| 2022 |
|---|
| 0 |
| 0 |
| 0 |
| - |
| - |
| - |
| 5,000 |
| - |
| - |
| - |
| 2023 |
|---|
| 0 |
| 8,307 |
| -8,307 |
| - |
| 0.18 |
| - |
| -3,307 |
| 4,045 |
| - |
| - |
| 2023 |
|---|
| 0 |
| 8,307 |
| -8,307 |
| - |
| 0.18 |
| - |
| -3,307 |
| 4,045 |
| - |
| - |
Turnover (zł)
2023
Turnover (zł)
0 zł
- *
Profit before tax (zł)
8,307 zł- *
Net Profit (zł)
-8,307 zł- *
Working capital requirement (%)
-Liquidity ratio
0.18 - *
Net profitability (%)
-Equity (zł)
-3,307 zł
-166 % *
Current liabilities (zł)
4,045 zł- *
Non current liabilities (zł)
-Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Order report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
21 MEDICAL INNOVATIONS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
30/10/2025 | OD 01.01.2024 DO 31.12.2024 |
28/10/2024 | OD 01.01.2023 DO 31.12.2023 |
21/09/2023 | OD 01.01.2022 DO 31.12.2022 |
03/01/2023 | OD 01.01.2021 DO 31.12.2021 |
27/07/2021 | OD 15.11.2019 DO 31.12.2020 |